Checkpoint Therapeutics, Inc. (CKPT) — Analyst outlook / Analyst consensus target is. Based on 7 analyst ratings, the consensus is bullish — 5 Buy, 2 Hold.
The consensus price target is $4.10, representing a downside of 3.8% from the current price $4.26.
CKPT Stock — 12-Month Price Forecast
$4.10
▼ -3.76% Downside
Average Price Target
Based on 7 Wall Street analysts offering 12-month price targets for Checkpoint Therapeutics, Inc., the price target is $4.10.
The average price target represents a -3.76% change from the last price of $4.26.
CKPT Analyst Ratings
Buy
Based on 7 analysts giving stock ratings to Checkpoint Therapeutics, Inc. in the past 3 months
